Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (81-90 of 627) with videos related to

Pageof 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.
Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.
The New England Journal of Medicine|June 13, 2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
American Heart Journal|April 29, 2008
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predictDerek P Chew, Kenneth W Mahaffey, Harvey D White, et al.
Pharmaceutical Statistics|April 9, 2015
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trialYumi Kubo, Lulu Ren Sterling, Patrick S Parfrey, et al.
The American Journal of Medicine|January 13, 2004
Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromesAbdallah G Rebeiz, Matthew T Roe, John H Alexander, et al.
Journal of Cardiac Failure|April 13, 2024
Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular EventsMuhammad Shahzeb Khan, James L Januzzi, Yuxi Liu, et al.
Journal of Pharmacy Practice|February 23, 2019
Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health AdministrationGeorge C Leef, Alexander C Perino, Mariam Askari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
Stroke|September 10, 1998
Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trialJ M Gebel, C A Sila, M A Sloan, et al.
Pageof 63

Showing results (81-90 of 627) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.
Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.
The New England Journal of Medicine|June 13, 2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
American Heart Journal|April 29, 2008
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predictDerek P Chew, Kenneth W Mahaffey, Harvey D White, et al.
Pharmaceutical Statistics|April 9, 2015
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trialYumi Kubo, Lulu Ren Sterling, Patrick S Parfrey, et al.
The American Journal of Medicine|January 13, 2004
Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromesAbdallah G Rebeiz, Matthew T Roe, John H Alexander, et al.
Journal of Cardiac Failure|April 13, 2024
Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular EventsMuhammad Shahzeb Khan, James L Januzzi, Yuxi Liu, et al.
Journal of Pharmacy Practice|February 23, 2019
Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health AdministrationGeorge C Leef, Alexander C Perino, Mariam Askari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
Stroke|September 10, 1998
Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trialJ M Gebel, C A Sila, M A Sloan, et al.
Pageof 63